[1]
T. Gonçalves, I. Alen Coutinho, J. S. Pita, and P. Leiria Pinto, “Successful off-label use of omalizumab in a child with chronic spontaneous urticaria”, REVNEC, vol. 33, no. 1, pp. 51–55, Apr. 2024.